EXAGEN INC. Purchase Agreements
16 Contracts & Agreements
- Amendment No. Six to Asset Purchase Agreement, dated February 16, 2017, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)
- Amendment No. Five to Asset Purchase Agreement, dated January 26, 2016, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)
- Amendment No. Four to Asset Purchase Agreement, dated October 8, 2013, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)
- Amendment No. Three to Asset Purchase Agreement, dated February 6, 2013, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)
- Amendment No. Two to Asset Purchase Agreement, dated August 21, 2012, by and between Royalty Pharma Collection Trust, Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)
- Amendment No. One to Asset Purchase Agreement, dated March 10, 2011, by and between Cypress Bioscience, Inc., Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)
- Asset Purchase Agreement, dated October 8, 2010, by and between Cypress Bioscience, Inc., Proprius, Inc. and the Registrant (Filed With SEC on August 23, 2019)
- Amendment No. Two to Asset Purchase Agreement, dated January 11, 2017, by and between the Registrant and Cellatope Corporation (Filed With SEC on August 23, 2019)
- Amendment No. One to Asset Purchase Agreement, dated December 14, 2012, by and between the Registrant and Cellatope Corporation (Filed With SEC on August 23, 2019)
- Asset Purchase Agreement, dated February 9, 2009, by and between the Registrant (as successor in interest to Cypress Bioscience, Inc.) and Cellatope Corporation (Filed With SEC on August 23, 2019)
- AMENDMENT NO. FIVE TO ASSET PURCHASE AGREEMENT (Filed With SEC on February 17, 2016)
- AMENDMENT NO. FOUR TO ASSET PURCHASE AGREEMENT AND CONSENT (Filed With SEC on February 17, 2016)
- AMENDMENT NO. ONE TO ASSET PURCHASE AGREEMENT BETWEEN CYPRESS BIOSCIENCE, INC. AND CELLATOPE CORPORATION (Filed With SEC on October 9, 2014)
- AMENDMENT NO. TWO TO ASSETPURCHASE AGREEMENT between: ROYALTY PHARMA COLLECTION TRUST, PROPRIUS, INC. and EXAGEN DIAGNOSTICS, INC. Datedas of August 21, 2012 AMENDMENT NO. TWO TO... (Filed With SEC on September 19, 2014)
- AMENDMENT NO. ONE TO ASSET PURCHASE AGREEMENT BETWEEN CYPRESS BIOSCIENCE, INC. AND CELLATOPE CORPORATION (Filed With SEC on September 19, 2014)
- ASSET PURCHASE AGREEMENT between: CYPRESS BIOSCIENCE, INC., a Delaware corporation and CELLATOPE CORPORATION, a Delaware corporation Dated as ofFebruary 9, 2009 ASSET PURCHASE... (Filed With SEC on September 19, 2014)
